Product
Sutezolid
Aliases
SZD
3 clinical trials
2 indications
Indication
TuberculosisIndication
Pulmonary TuberculosisClinical trial
A Novel 4-month Pan-TB Regimen Targeting Both Host and Microbe (panTB-HM)Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisStatus: Not yet recruiting, Estimated PCD: 2025-06-10
Clinical trial
A Phase IIB, Open-Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Sutezolid in Combination With Bedaquiline, Delamanid and Moxifloxacin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-sensitive Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2022-09-30